These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 20861162

  • 1. Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.
    Niesor EJ, Magg C, Ogawa N, Okamoto H, von der Mark E, Matile H, Schmid G, Clerc RG, Chaput E, Blum-Kaelin D, Huber W, Thoma R, Pflieger P, Kakutani M, Takahashi D, Dernick G, Maugeais C.
    J Lipid Res; 2010 Dec; 51(12):3443-54. PubMed ID: 20861162
    [Abstract] [Full Text] [Related]

  • 2. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.
    Briand F, Thieblemont Q, Muzotte E, Burr N, Urbain I, Sulpice T, Johns DG.
    Eur J Pharmacol; 2014 Oct 05; 740():135-43. PubMed ID: 25008069
    [Abstract] [Full Text] [Related]

  • 3. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
    Niesor EJ.
    Curr Opin Lipidol; 2011 Aug 05; 22(4):288-95. PubMed ID: 21587074
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.
    Johns DG, Chen Y, Wang SP, Castro-Perez J, Previs SF, Roddy TP.
    Eur J Pharmacol; 2015 Sep 05; 762():256-62. PubMed ID: 26049012
    [Abstract] [Full Text] [Related]

  • 5. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH, Akhlaghi F.
    Clin Pharmacokinet; 2013 Aug 05; 52(8):615-26. PubMed ID: 23658137
    [Abstract] [Full Text] [Related]

  • 6. In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.
    Wang SP, Daniels E, Chen Y, Castro-Perez J, Zhou H, Akinsanya KO, Previs SF, Roddy TP, Johns DG.
    J Lipid Res; 2013 Oct 05; 54(10):2858-65. PubMed ID: 23898048
    [Abstract] [Full Text] [Related]

  • 7. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.
    Yamashita S, Ruscica M, Macchi C, Corsini A, Matsuzawa Y, Sirtori CR.
    Atherosclerosis; 2018 Nov 05; 278():286-298. PubMed ID: 30347344
    [Abstract] [Full Text] [Related]

  • 8. Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.
    Shinkai H.
    Vasc Health Risk Manag; 2012 Nov 05; 8():323-31. PubMed ID: 22661899
    [Abstract] [Full Text] [Related]

  • 9. Biochemical characterization of cholesteryl ester transfer protein inhibitors.
    Ranalletta M, Bierilo KK, Chen Y, Milot D, Chen Q, Tung E, Houde C, Elowe NH, Garcia-Calvo M, Porter G, Eveland S, Frantz-Wattley B, Kavana M, Addona G, Sinclair P, Sparrow C, O'Neill EA, Koblan KS, Sitlani A, Hubbard B, Fisher TS.
    J Lipid Res; 2010 Sep 05; 51(9):2739-52. PubMed ID: 20458119
    [Abstract] [Full Text] [Related]

  • 10. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
    Niesor EJ, Chaput E, Staempfli A, Blum D, Derks M, Kallend D.
    Atherosclerosis; 2011 Dec 05; 219(2):761-7. PubMed ID: 21982411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U, D'Souza W, Mukhamedova N, Blum D, Niesor E, Mizrahi J, Maugeais C, Sviridov D.
    Cardiovasc Res; 2008 Mar 01; 77(4):732-9. PubMed ID: 18056760
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.
    Brodeur MR, Rhainds D, Charpentier D, Mihalache-Avram T, Mecteau M, Brand G, Chaput E, Perez A, Niesor EJ, Rhéaume E, Maugeais C, Tardif JC.
    J Lipid Res; 2017 Jul 01; 58(7):1282-1291. PubMed ID: 28515138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.